ATE244221T1 - Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE244221T1 ATE244221T1 AT98402926T AT98402926T ATE244221T1 AT E244221 T1 ATE244221 T1 AT E244221T1 AT 98402926 T AT98402926 T AT 98402926T AT 98402926 T AT98402926 T AT 98402926T AT E244221 T1 ATE244221 T1 AT E244221T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- production
- compositions containing
- containing same
- pyrrole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9714840A FR2771412B1 (fr) | 1997-11-26 | 1997-11-26 | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE244221T1 true ATE244221T1 (de) | 2003-07-15 |
Family
ID=9513802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98402926T ATE244221T1 (de) | 1997-11-26 | 1998-11-25 | Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6063804A (de) |
| EP (1) | EP0921119B1 (de) |
| JP (1) | JPH11228538A (de) |
| CN (1) | CN1126737C (de) |
| AT (1) | ATE244221T1 (de) |
| AU (1) | AU739179B2 (de) |
| BR (1) | BR9805053A (de) |
| CA (1) | CA2254521C (de) |
| DE (1) | DE69816004T2 (de) |
| DK (1) | DK0921119T3 (de) |
| ES (1) | ES2202775T3 (de) |
| FR (1) | FR2771412B1 (de) |
| HK (1) | HK1020945A1 (de) |
| HU (1) | HUP9802749A2 (de) |
| NO (1) | NO311716B1 (de) |
| NZ (1) | NZ333000A (de) |
| PL (1) | PL329894A1 (de) |
| PT (1) | PT921119E (de) |
| ZA (1) | ZA9810834B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| BR0008060A (pt) * | 1999-12-08 | 2002-02-05 | Pharmacia Corp | Composições inibidoras de ciclooxigenase-2 tendo rápido inìcio de eficácia terapêutica |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| PE20021017A1 (es) | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
| UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| KR100821915B1 (ko) | 2006-11-10 | 2008-04-16 | 한양대학교 산학협력단 | 2번 위치에 엑소 메틸렌기를 가지는 고리화합물이 치환된 다중 고리화합물 및 이의 제조방법 |
| CA2870931A1 (en) * | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Isoindolone derivatives |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6417202B1 (en) * | 1996-07-11 | 2002-07-09 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin-and TNF antagonists |
-
1997
- 1997-11-26 FR FR9714840A patent/FR2771412B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-24 CA CA002254521A patent/CA2254521C/fr not_active Expired - Fee Related
- 1998-11-25 PL PL98329894A patent/PL329894A1/xx unknown
- 1998-11-25 ES ES98402926T patent/ES2202775T3/es not_active Expired - Lifetime
- 1998-11-25 NZ NZ333000A patent/NZ333000A/xx unknown
- 1998-11-25 DK DK98402926T patent/DK0921119T3/da active
- 1998-11-25 JP JP10333554A patent/JPH11228538A/ja active Pending
- 1998-11-25 BR BR9805053-2A patent/BR9805053A/pt not_active IP Right Cessation
- 1998-11-25 PT PT98402926T patent/PT921119E/pt unknown
- 1998-11-25 AT AT98402926T patent/ATE244221T1/de not_active IP Right Cessation
- 1998-11-25 NO NO19985495A patent/NO311716B1/no unknown
- 1998-11-25 EP EP98402926A patent/EP0921119B1/de not_active Expired - Lifetime
- 1998-11-25 US US09/199,640 patent/US6063804A/en not_active Expired - Fee Related
- 1998-11-25 DE DE69816004T patent/DE69816004T2/de not_active Expired - Fee Related
- 1998-11-26 AU AU94165/98A patent/AU739179B2/en not_active Ceased
- 1998-11-26 HU HU9802749A patent/HUP9802749A2/hu unknown
- 1998-11-26 CN CN98122801A patent/CN1126737C/zh not_active Expired - Fee Related
- 1998-11-26 ZA ZA9810834A patent/ZA9810834B/xx unknown
-
1999
- 1999-09-03 US US09/390,416 patent/US6114360A/en not_active Expired - Fee Related
- 1999-12-03 HK HK99105666A patent/HK1020945A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT921119E (pt) | 2003-10-31 |
| US6063804A (en) | 2000-05-16 |
| HK1020945A1 (en) | 2000-05-26 |
| JPH11228538A (ja) | 1999-08-24 |
| PL329894A1 (en) | 1999-06-07 |
| NO311716B1 (no) | 2002-01-14 |
| CN1126737C (zh) | 2003-11-05 |
| HUP9802749A2 (hu) | 2001-02-28 |
| BR9805053A (pt) | 2000-02-01 |
| FR2771412B1 (fr) | 2000-04-28 |
| CA2254521C (fr) | 2003-10-28 |
| DE69816004D1 (de) | 2003-08-07 |
| NZ333000A (en) | 2000-04-28 |
| AU9416598A (en) | 1999-06-17 |
| US6114360A (en) | 2000-09-05 |
| NO985495L (no) | 1999-05-27 |
| CA2254521A1 (fr) | 1999-05-26 |
| HU9802749D0 (en) | 1999-01-28 |
| NO985495D0 (no) | 1998-11-25 |
| ZA9810834B (en) | 1999-05-31 |
| EP0921119B1 (de) | 2003-07-02 |
| EP0921119A1 (de) | 1999-06-09 |
| AU739179B2 (en) | 2001-10-04 |
| DK0921119T3 (da) | 2003-10-20 |
| CN1222509A (zh) | 1999-07-14 |
| DE69816004T2 (de) | 2004-04-29 |
| FR2771412A1 (fr) | 1999-05-28 |
| ES2202775T3 (es) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9203318D0 (sv) | Novel 3,3-diphenylpropylamines, their use and preparation | |
| ATE150462T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung | |
| DE69110625D1 (de) | Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen. | |
| ES2029384T3 (es) | Procedimiento para preparar nuevas 3,3-difenilpropilaminas. | |
| ATE244221T1 (de) | Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| NO940523D0 (no) | Nye pyrazin-derivater | |
| AR036176A1 (es) | Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado | |
| WO2002007677A3 (en) | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | |
| DE3575554D1 (de) | Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen. | |
| AR042547A1 (es) | Uso de acidos alfa - feniltiocaboxilico y alfa - feniloxicarboxilico con actividad disminuidora de la glucosa en el suero y de los lipidos en el suero | |
| ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DK0861250T3 (da) | Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase | |
| DE68906572D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE3787844D1 (de) | Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen. | |
| HRP20000733B1 (en) | NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS | |
| EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
| ATE86993T1 (de) | Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| ATE7137T1 (de) | Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
| EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| DE68909451D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| TH37589A (th) | อนุพันธ์พิริดีนชนิดใหม่และสารผสมทางเภสัชกรรมที่มีสารเหล่านี้ | |
| TH6636EX (th) | อนุพันธ์ของควิโนลีน กรรมวิธีสำหรับการเตรียมสารเหล่านั้นและสารต่อต้านแบคทีเรีย ที่มีสารเหล่านั้นอนุพันธ์ของควิโนลีน กรรมวิธีสำหรับการเตรียมสารเหล่านั้นและสารต่อต้านแบคทีเรีย ที่มีสารเหล่านั้น |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0921119 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |